Drawing for BIOGRID

USPTO serial 87715385

BIOGRID

Reviewed by CopyMark Law Group

Reg. 5614826Status 705Registered
Filing date
Status date
Registration date
Nov 27, 2018
Examiner
JACKSON, STEVEN W
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights. Track next renewal deadlines in TSDR and WIPO records.

Status 705: Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights.

Need help with BIOGRID?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Daniel M. Gurfinkel

Daniel M. Gurfinkel Dennemeyer & Associates, LLC230 W. Monroe St.Suite 2100CHICAGO, IL 60606

Goods and services

ClassDescriptionStatusFirst use
009Measuring instruments, namely, microfluidic components and devices and micro electro mechanical wafers and substrates, to be used for the development, testing, research and analysis of pharmaceutical products, for chemical research and analysis, for testing, research and analysis of biological substances and for screening and characterization of nucleic acid, all being laboratory equipment and devices not used for medical purposes; accessories, namely, microfluidic components and microfluidic devices and micro electro mechanical wafers and substrates; microfluidic components and microfluidic devices and micro electro mechanical wafers and substrates for the development, testing, research and analysis of chemical and biological products and substances for laboratory equipment and instruments; laboratory plates; glassware for laboratory use; glassware for scientific experiments in laboratories; products, namely, microfluidic and micro-electromechanical components, devices, microfluidic and micro-electromechanical substrates in the nature of silicon, polymer, metal, glass and microfluidic and micro-electromechanical chips, sensor chips, monitoring chips, biochips, flow cell chips for research, diagnostic, testing and analysis of pharmaceutical, biomedical, biochemical, biological products and substances for scientific purposes in the pharmaceutical, chemical, medical, biological and clinical fields, all being laboratory equipment and devices not used for medical purposes from biologically active glass; products, namely, sensor chips, monitoring chips, biochips, flow cell chips for research, diagnostic, testing and analysis of pharmaceutical, biomedical, biochemical, biological products and substances for scientific purposes in the pharmaceutical, chemical, medical, biological and clinical fields, all being laboratory equipment and devices not used for medical purposes made of chemically active glassACTIVE—
010[ Medical equipment accessories, namely, components and devices with microfluidic capabilities and micro-electromechanical components in the nature of chips for electronic analysis devices; medical equipment accessories, namely, components and devices with microfluidic capabilities and micro-electromechanical components in the nature of chips for physical analysis devices; medical equipment accessories, namely, components and devices with microfluidic capabilities and micro-electromechanical components in the nature of chips for automatic analysis devices for biotechnological applications; equipment, namely, lab-on-chip, droplet generators, micromixers, micro reactors, flow cells from substrates of glass, metal, silicon, polymers for carrying out analytical processes, medical diagnostic functions, medical research and analysis for monitoring blood properties and properties of other body liquids, artificial substitutes for blood and other body liquids, respiratory events, monitoring and culturing of cells and tissues, cancer treatment, and early detection and treatment of infectious diseases; analytical, diagnostic and testing devices for medical or veterinary purposes, namely blood analyzers, breath analyzers, capillary electrophoresis separators for medical purposes, conductivity detectors for medical purposes, dialysis apparatus, medical electro-osmotic flow devices for measuring arterial blood flow, fluorescence detectors for medical purposes, urine analyzers for medical purposes; all the aforementioned goods being non-implantable medical devices for the analysis of substances for medical purposes ]SECTION 8 - CANCELLED—
040[ Surface treatment of materials in the nature of glass; treatment of materials in the nature of glasses for changing optical properties ]SECTION 8 - CANCELLED—
042[ Scientific research and development; product research and development; research and development in the field of biotechnology; design and development for others of scientific equipment for biotechnological applications; consulting services in the field of biotechnology ]SECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 3, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Mar 3, 2025C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Mar 3, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 29, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Nov 27, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 27, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 11, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 11, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 22, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 6, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 18, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 18, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 16, 2018ALIEASSIGNED TO LIE—
Jul 3, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 24, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 24, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 24, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2018DOCKASSIGNED TO EXAMINER—
Dec 20, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 14, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance